Dr. Young on the Challenges of Using Anticoagulants in Children With Cancer

Guy Young, MD
Published: Tuesday, Nov 28, 2017



Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, discusses the challenges of using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is challenging because children have a higher risk of experiencing day-to-day trauma, says Young. Traumas such as a scraped knee are a normal occurrence for children, but when on an anticoagulant, the risk of bleeding is much higher.
 


Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, discusses the challenges of using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is challenging because children have a higher risk of experiencing day-to-day trauma, says Young. Traumas such as a scraped knee are a normal occurrence for children, but when on an anticoagulant, the risk of bleeding is much higher.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Cancer Summaries and Commentaries™: Update from San Diego - Advances in the Treatment of Multiple MyelomaJan 31, 20181.5
Publication Bottom Border
Border Publication
x